• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy AI in health care: The perils of Biden’s executive order
Economy

AI in health care: The perils of Biden’s executive order

by December 5, 2023
by December 5, 2023 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

In an audacious move, the White House recently issued a staggering 111-page executive order on Artificial Intelligence. 

Typically, executive orders are concise directives, prompting federal agencies to craft specific, detailed regulations. However, this sweeping document reflects the worldview that AI isn’t just a technological advancement; it’s an existential societal threat and only the government holds the keys to our technological salvation.

For those committed to health care access and affordability, the regulatory scope of this AI-focused executive order is alarming. Artificial intelligence stands on the cusp of revolutionizing health care – from groundbreaking drug discoveries to enhancing patient care and reducing unanticipated clinical deterioration, promising a foreseeable future where getting the right treatment to the right patient and at the right time is rapidly becoming a reality. 

Given that much of the current health care system’s dysfunction stems from excessive government rules and red tape, the Biden administration’s default stance that views AI’s transformative power in health care as a significant threat should come as no surprise. After all, AI promises to transform systems traditionally under significant government influence and control.

One recent study estimates that current AI technology could slash annual health care costs by an astounding $360 billion, with about 35% of these savings coming from streamlined administrative tasks. 

Consider the time spent on administrative functions: physicians spend an average of 15.5 hours per week on paperwork. With AI, there’s a tangible opportunity to shift focus from computer keyboards back to patients, enhancing both the quality and quantity of time devoted to patient care, eliminating bureaucratic waste in favor of fortifying the crucial patient-physician relationship.

The potential of AI to transform the doctor’s office is just the tip of the iceberg. When we extrapolate this to government bureaucracy, the possibilities are even more staggering. 

If AI can streamline health care processes, reducing time and costs while improving patient care, imagine the efficiency and effectiveness it could bring to the often opaque and duplicative workings of government agencies. And maybe that is the point of federal government control over AI in health care. 

President Biden’s rhetoric isn’t matching the reality of what the EO would do to health care innovation: on one hand, it professes to champion innovation in AI, but on the other, it burdens the health care industry with compliance costs that only the market giants can likely absorb, squeezing out smaller players. 

The order also calls for greater transparency but then imposes reporting requirements that could hinder open-source AI development, a cornerstone of collaborative and rapid innovation in the field. 

These contradictory stances extend to workforce implications as well. The requirement for the Department of Labor to collaborate with labor unions in addressing AI’s potential job displacement risks prioritizing government union protectionism over patient well-being, as well as health care innovation and progress.

The promises of AI are not theoretical, the risks largely are. Consider that the FDA has already approved or certified hundreds of AI and machine-learning enabled medical devices. 

AI is making it possible to detect harmful diseases in blood with up to 95% accuracy, predict heart attack risk up to a decade in advance, and conduct phenotype and genotype analyses to provide diagnoses and treatments for rare and ultra-rare diseases years earlier than what was previously possible.

Bias in AI is a risk that policymakers frequently raise. To address the issue, the health care sector is harnessing AI’s computing power to use larger, more varied data sets and fostering the creation of alternative algorithms. This approach allows for a more comprehensive representation of patients, encompassing various factors like race, ethnicity, gender and age. 

In addition, the ability to use multiple, competing algorithms can help identify and counteract biases that might go unnoticed in a single algorithm – and has been a long-recognized issue in centralized clinical trials for decades.

It’s also crucial to recognize that AI can outperform clinical trials in predicting outcomes. According to the Tufts Center for the Study of Drug Development, a Phase 3 trial can generate, on average, 3.6 million data points, which is three times the amount of data available a decade ago. 

As medical innovation progresses, the ability of AI to further decentralize trials, swiftly analyze genetic data for the development of customized treatments and those targeting rare- and ultra-rare diseases, and to offer more reliable and efficient predictions is increasingly available.

Every regulation that stifles the creation of new treatments carries a human cost: the ‘what might have been’ had bureaucracy not been in the way. It’s an accounting of disease burden, lost time with loved ones, and lives ended too soon. 

Naomi Lopez is a co-founder of the AI in Healthcare Working Group.

This post appeared first on FOX NEWS
You Might Also Like
  • Biden tells donors Israel is losing support globally
  • Biden slammed after giving his ‘word as a Biden’ that America’s future looks great: ‘We’re screwed’
  • 12 NJ mayors raise alarm on offshore wind after ‘unprecedented’ number of whale deaths
  • Christie jeered after criticizing Trump at faith event: ‘You can boo all you want’
Share
0
FacebookTwitterPinterestWhatsapp

previous post
DP Trading Room: How Bad Data From Major Indexes Leads to Bad Analysis
next post
IRS whistleblowers to testify behind closed doors amid Biden impeachment inquiry

You may also like

Meadows mugshot released after turning himself in for Trump-Georgia case...

August 25, 2023

Biden campaign, Blinken orchestrated intel letter to discredit Hunter Biden...

April 21, 2023

Minyon Moore, former Black Lives Matter board member, announced as...

August 9, 2023

Bitcoin Hits All-Time High, Ethereum Breaks Key Resistance

November 8, 2024

Hunter Biden wants gun and tax cases tossed, citing Trump...

July 19, 2024

Swing state voters tell NYT why they’re ditching Biden for...

May 18, 2024

Could verdict in Trump criminal trial upend the presidential election?

May 29, 2024

Take two: Ohio’s Matt Dolan announces second straight Senate run,...

January 16, 2023

Trump’s 2024 GOP rivals weigh in on former president’s January...

August 2, 2023

Ohio marijuana legalization proposal set to appear on statewide ballots...

August 17, 2023

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Clusters of Long Winning Streaks: What They’re Telling Us

      June 5, 2025
    • This California startup is cleaning water and removing CO₂ from the atmosphere — all at a reduced cost

      June 5, 2025
    • OpenAI tops 3 million paying business users, launches new features for workplace

      June 5, 2025
    • Why ADX Can Mislead You — And How to Avoid It

      June 4, 2025
    • S&P 500 on the Verge of 6,000: What’s at Stake?

      June 4, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,786 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,491 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,472 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,453 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,330 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,118)
    • Investing (538)
    • Stock (2,591)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Clusters of Long Winning Streaks: What They’re Telling Us

      June 5, 2025
    • This California startup is cleaning water and removing CO₂ from...

      June 5, 2025
    • OpenAI tops 3 million paying business users, launches new features...

      June 5, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,118)
    • Investing (538)
    • Stock (2,591)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    New York AG Letitia James appeals...

    March 21, 2023

    Gay Trump voters shatter Dem ‘lie’...

    June 21, 2024

    Biden to officially announce re-election bid...

    April 21, 2023
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here